Phase III Randomized Study of Crenolanib versus Midostaurin Administered Following Induction Chemotherapy and Consolidation Therapy in Newly Diagnosed Subjects with FLT3 Mutated Acute Myeloid Leukemia
NOT ENROLLING
Trial ID:
NCT03258931 Protocol # :
17-623
Phase
III
Disease Sites
Myeloid and Monocytic Leukemia
Principal Investigator
Stone, Richard, M
Site Investigator
Dias, Ajoy, L.
Fathi, Amir, T.
McMasters, Malgorzata
Trial Description
Call 877-DF-TRIAL (877-338-7425) to learn more about this clinical trial, protocol #17-623
17-623